The high-output pathway of nitric oxide production helps protect mice from infection by several pathogens, including Mycobacterium tuberculosis. However, based on studies of cells cultured from blood, it is controversial whether human mononuclear phagocytes can express the corresponding inducible nitric oxide synthase (iNOS; NOS2). The present study examined alveolar macrophages fixed directly after bronchopulmonary lavage. An average of 65% of the macrophages from 11 of 11 patients with untreated, culture-positive pulmonary tuberculosis reacted with an antibody documented herein to be monospecific for human NOS2. In contrast, a mean of 10% ofbronchoalveolar lavage cells were positive from each of five clinically normal subjects. Tuberculosis patients' macrophages displayed diaphorase activity in the same proportion that they stained for NOS2, under assay conditions wherein the diaphorase reaction was strictly dependent on NOS2 expression. Bronchoalveolar lavage specimens also contained NOS2 mRNA. Thus, macrophages in the lungs of people with clinically active Mycobacterium tuberculosis infection often express catalytically competent NOS2.
Summary
The high-output pathway of nitric oxide production helps protect mice from infection by several pathogens, including Mycobacterium tuberculosis. However, based on studies of cells cultured from blood, it is controversial whether human mononuclear phagocytes can express the corresponding inducible nitric oxide synthase (iNOS; NOS2). The present study examined alveolar macrophages fixed directly after bronchopulmonary lavage. An average of 65% of the macrophages from 11 of 11 patients with untreated, culture-positive pulmonary tuberculosis reacted with an antibody documented herein to be monospecific for human NOS2. In contrast, a mean of 10% ofbronchoalveolar lavage cells were positive from each of five clinically normal subjects. Tuberculosis patients' macrophages displayed diaphorase activity in the same proportion that they stained for NOS2, under assay conditions wherein the diaphorase reaction was strictly dependent on NOS2 expression. Bronchoalveolar lavage specimens also contained NOS2 mRNA. Thus, macrophages in the lungs of people with clinically active Mycobacterium tuberculosis infection often express catalytically competent NOS2.
A
third of the world's human population is thought to be infected with Mycobacterium tuberculosis (1) . Though the vast majority of individuals hold the organism in check, more than 2.5 million a year fail to do so. As a result, tuberculosis may be the world's leading cause of death from bacterial infection (1). It is not known how human macrophages normally suppress the proliferation of this facultative intracellular pathogen nor how the bacterium sometimes gains the upper hand.
The inducible isoform of nitric oxide synthase (iNOS, NOS2) 1 contributes to the control of viral, bacterial, proto~Abbreviations used in this paper: BSA/ggg, 5% BSA and 100 p.g/ml goat ~-globulin in Tris-buffered saline; ECL, enhanced chemiluminescence; HUVEC, human umbilical vein endothelial cells; NGS, normal goat serum; NOS, nitric oxide synthase; PAGE, polyacrylamide gel electrophoresis; RT, room temperature; RT-PCR, reverse transcription followed by polymerase chain reaction; TBS, Tris-buffered saline.
Drs. Nicholson, Bonecini-Almeida, and Lapa e Silva contributed equally to this study. zoal, fungal, and helminthic infections in mice (reviewed in references 2 and 3). This is evident from coordinate expression of NOS2 and anti-infectious activity; exacerbation of infection in vitro and in vivo by administration ofNOS inhibitors; conferral of anti-infectious activity upon transfection with NOS2 cDNA or exposure to NO-generating organochemicals; and enhanced vulnerability to infection in mice rendered genetically deficient in NOS2 (4, 5) . By the first three criteria, control of experimental tuberculosis in mice is NO-dependent (6-9). Moreover, mice rendered genetically deficient in interferon-~/ (10), its receptor (11), or interferon regulatory factor-1 (12) are all disadvantaged with respect to expression of NOS2, and all three mouse strains sustain rapid mycobacterial proliferation.
However, the ability of human mononuclear phagocytes to express NOS2 is contested (13) (14) (15) . Denis obtained the first positive evidence: nitrite in the medium of cytokinetreated, mycobacteria-infected, monocyte-derived macrophages (16) . Support followed from at least 16 additional laboratories experimenting with various forms of induction and detection (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) . Nonetheless, comparable results have eluded many other investigators (e.g., [33] [34] [35] [36] [37] , some of whom dismiss the evidence that human mononuclear phagocytes can express NOS2 at all (14) or at a level consonant with host defense (38) .
One interpretation of this controversy is that unidentified variables may restrict the consistency with which human monocytes or macrophages can be induced to express NOS2 in vitro. Such suppressive influences may not pertain in vivo. On this premise, we examined pulmonary alveolar macrophages fixed immediately after collection from patients with tuberculosis. Since monocytes can express NOS2 mtLNA without detectable NOS2 protein (25) , we centered the study on the characterization of an antibody--apparently the first such reagent--with which expression of human NOS2 protein could be demonstrated unequivocally. The results document the frequent expression of catalytically competent NOS2 in human macrophages from a site of infection.
Materials and Methods
Antibody. A peptide (Cys-Arg-Nle-Orn-Ser-Leu-Glu-MetSer-Ala-Leu) was synthesized to correspond to the 7 COOH-terminal residues of human NOS2 (underlined) plus 4 additional residues to improve solubility, linkage and quantitation. This peptide was coupled to thyroglobulin as described (39) . IgG was purified from serum of a normal rabbit on recombinant staphylococcal protein A columns (Pierce Chemicals, R.ockford, IL). The same rabbit was then repeatedly immunized with the peptide conjugate, initially in Freund's complete adjuvant and then in Freund's incomplete adjuvant. IgG was purified from the antisera, collectively termed NO53. F(ab')2 fragments were prepared by digestion with immobilized pepsin (Pierce) and purified as above. The synthetic peptide NO54 (Tyr-Arg-Ala-Ser-Leu-Glu-MetSer-Ala-Leu) was used as a competitive blocking agent for immunoblots and immunocytochemistry. R.abbit antibody to pure mouse NOS2 was described (40) . Affinity-purified rabbit antibodies to synthetic peptides from rat NOS1 (amino acid residues 1400-1419, containing a single amino acid difference from human NOS1) and human NOS3 (residues 1183-1202) were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA) and were used at 0. Immunoblotting. Human NOS2 is susceptible to primary structural degradation when boiled in Laemmli's buffer (J. Calaycay and Q.-w. Xie, unpublished observations). Accordingly, unheated lysates were electrophoresed under denaturing, reducing conditions on 7.5% polyacrylamide gels, blotted to Immobilon membranes (Millipore Corp., Bedford, MA), and probed with NO53 IgG at 4 ng/ml or its F(ab')2 fragment at 132 ng/ml. Bound rabbit Ig was detected with donkey anti-rabbit IgG conjugated with horseradish peroxidase (Amersham Corp., Arlington Heights, IL) as revealed by enhanced chemiluminescence (Du Pont, Boston, MA).
(Immuno)Cytochemistry. Slides were blocked for 60 rain at room temperature (R.T) in 10% normal goat serum (NGS) in Tris-buffered saline (TBS), incubated for 60 rain in 4 ng/ml preimmune IgG or NO53 IgG or 132 ng/ml of its F(ab')2 in NGS/ TBS with or without 10 ~g/ml of blocking peptide NO54, washed three times (5 rain each) in TBS, and then incubated 60 rain in 1:500 dilution of goat IgG anti-rabbit IgG conjugated to biotin (Vector Labs.). After washing, the slides were incubated in avidin-conjugated alkaline phosphatase according to the manufacturer's instructions (ABC Kit: Vector Labs.), washed thrice in TBS, and then incubated in Vector (Texas) R.ed or Vector Blue substrate for "~20 nfin. Slides were coverslipped in 10% glycerol and percent positive cells scored among 500 cells per sample under direct illumination (4005<). For illustrative purposes, some slides developed with Vector R.ed were also photographed under epifluorescence with a Nikon B excitation filter (bandpass, 460--485 nm). With this filter, macrophage autofluorescence appeared yellow-green, allowing a clear distinction from positive staining (red). Emission intensity from Texas red under these conditions of excitation was expected to be only ,'-~13% of that for excitation at 596 nm; nonetheless, the signal was brighter than by brightfield.
Some specimens stained with preimmune IgG, and this reactivity was not blocked by peptide NO54. Staining with these characteristics was deemed nonspecific. In an attempt to circumvent nonspecific reactivity, we tried to affinity-purify NO53 on NO54 coupled to solid supports. However, the affinity of NO53 for NO54 was so high that no antibody could be eluted (J. Calaycay and J.1K. Weidner, unpublished observations). We therefore capitalized on the high affinity of specific NO53-antigen interaction by applying an acid wash in situ to disrupt nonspecific interactions, as follows. Slides from samples that showed staining by preimmune serum as developed in Vector Blue were decolotized in xylene for 20 min. Slides developed in Vector Ked could not be decolorized; when available, fresh slides from such patients were submitted to the same procedures. The air-dried slides were blocked in 5% BSA, 100 ~g/ml goat "/-globulin in TBS (BSA/ ggg) for 60 min, then incubated in preimmune IgG, NO53, or NO53 plus NO54 as above, the reagents being diluted in BSA/ ggg. The samples were then incubated for 30 rain at 1KT in 50 mM glycine buffer, pH 2.5, washed twice in TBS, and developed with the second antibody and avidin-alkaline phosphatase ABC reagents as above, using either Vector Red or Vector Blue as substrates. As controls, slides that had been processed according to the standard procedure and showed only specific staining were subjected to the alternative procedure; they gave the same percent positive ceils as before. Slides that showed nonspecific staining according to the standard procedure showed no staining after the alternate procedure.
Other slides were stained by standard procedures using monoclonal antibodies to CD3, CD4, or CD8 (Coulter Corp., Hialeah, FL).
To detect enzymatic activity, companion slides were incubated in 50 mM Tris, pH 8, with 0.3 mM nitroblue tetrazolium (Sigma), 1 mM NADPH, 0.2% Triton X-100 for 30 rain at 370C, washed, mounted in glycerol, and scored as above under bright-field illumination.
RT-PCR. From 16 culture-positive tuberculosis patients and
2 healthy volunteers each from Rio de Janeiro and New York, bronchoalveolar lavage ceils were available that had been stored in 1KNA Stat-60 (Tel-Test B, Inc., Friendswood, TX) at -70~ Human 293 cells transfected with NOS2 cDNA (42) or vector alone constituted positive and negative controls. Total RNA (1 Ixg) was reverse-transcribed using oligo-d(T)~ 6 and PC1K performed by standard methods (GeneAmp system 9600; Perkin Elmer). First-round PC1K was carried out with 20% of the cDNA using oligonucleotide with primers from exon 1 (5'-CAC CTT TGA TGA GGG GAC-3') and exon 4 (5'-GCA TCC AGC TTG ACC AG-3') of human NOS2 (44) . For nested PCR, 4% of the first-round product was amplified with primers from exon 1 (5'-ATG AGG GGA CTG GGC AGT TC-3') and exon 4 (5'-GCT TGA CCA GCG ATT CTG GAG-3'). After electrophoresis in 1.5% agarose, reaction products (10 I~i) were transferred to nylon membranes (Nytran-Plus; Schleicher & Schuell, Keene, NH) and autoradiographed after probing with 32p-labeled oligonucleotide derived from a sequence of NOS2 internal to the primers (5'-CCT TAC CCC GGG GAG GCA GTG CAG CCA G'3').
Cloning and Sequencing of NOS2 R T-PCR Products.
Nested IKT-PC1K products from 3 patients and 1 healthy control were excised from the electrophoretic gel and purified (Qiagen, Chatworth, CA). The DNA was ligated into the EcolKV site of the pT7Blue vector containing the lacZ ot-peptide (Novagen, Madison, WI) and transformed into E. coli NovaBlue competent cells, expressing the LacZ-r fragment. Transformed cells were grown on LB agar containing ampicillin, X-gal and isopropyl ~-D-thiogalactopyranoside. Five clones from each transformant were selected and the presence of the cloned DNA fragment confirmed by restriction with BamHI and Sail. At least one clone from each transformant was sequenced (373 DBA sequencer; Applied Biosystems, Foster City, CA).
Results
Characterization of Anti-NOS2 Antibody. Antibody NO53 was raised against a synthetic pepfde that contains the extreme COOH-terminal heptamer of human NOS2, a sequence not represented elsewhere in the currently available protein data base. In particular, this sequence is absent from human NOS1, human NOS3, and mouse NOS2. Antibody NO53 reacted with peptide NO54 in ELISA with a titer of 1:400,000 (not shown). When 293 cells were transfected with human NOS2 cDNA, NO53 immunoblotted a single polypeptide species whose apparent molecular mass ('-d33 kD) corresponded to that of the NOS2 monomer.
Immunoreactivity was abolished by a molar excess of peptide NO54, and was absent using preimmune IgG from the same rabbit (Fig. 1) . Immunocytochemistry confirmed the reactivity of NO53 with 293 cells transfected with human NOS2, and not those transfected with vector alone. That the epitope recognized by NO53 was represented in the COOH terminus of human NOS2 was demonstrated by the ability of NO53 to immunoblot 293 cells transfected with a chimeric construct in which the COOH terminus of mouse NOS2 was replaced with the corresponding region from human NOS2 (Fig. 1) . In contrast, NO53 could not react with full-length mouse NOS2. Expression of the latter was confirmed by its reactivity with anti-mouse NOS2 antibody (Fig. 1) . When 293 cells were transfected with human NOS1 cDNA, they remained NO53-negative by immunoblot and immunofluorescence. Similarly, lysates of human umbilical vein endothelial cells (HUVEC) were not immunoblotted by NO53. NOSl-transfected 293 cells were immunoblot-positive with anti-NOS1 antibody, and HUVEC were immunoblot-positive with anti-NOS3 antibody, proving the presence of the isoforms with which NO53 did not react (Fig. 1) . Because Freund's complete adjuvant was used to raise NO53, it was necessary to exclude the possibility that the antibody might also react with mycobacterial antigens. NO53 did not immunoblot a lysate prepared from 109 bacilli of M. tuberculosis H371La (the strain used in Freund's complete adjuvant) (Fig. 1) . Moreover, when human monocytes were productively infected with M. tuberculosis H371Ka, they remained nonreactive with NO53 (Almeida, G., H. Cho, C. Nathan and J. Ho, unpublished observations).
Thus, NO53 appeared to react with a COOH-terminal epitope of human NOS2, but not with mouse NOS2, human NOS1, human NOS3, any other proteins in a human epithelial cell line, other proteins in human macrophages, or mycobacterial antigens expressed in broth culture or in macrophages. 3% of the total cell population as assessed by expression of CD3 or the combination of CD4 + CD8 (whichever was greater), whereas 10 • 4% of the cells were polymorphonuclear leukocytes and 0.9 • 0.3% were scored morphologically as epithelial cells. The rest o f the lavage cells (75 • 5%) and 100 • 0% o f the NO53-positive cells had morphologic characteristics of macrophages (Figs. 2, 3) . Thus, on average, 65% of the macrophages were NOS2-positive. Results were no higher for the subset o f subjects who smoked tobacco (39 • 15% o f lavage cells; n = 6) than those who did not (60 + 15% oflavage cells; n = 4); the smoking status o f one subject was unknown.
Immunoreactivity of Macrophages from
In lavage specimens from 5 nonsmoking normal donors, 10 • 5% of the cells (almost all of which were macrophages) stained with N O 5 3 (range 2-16%) (Fig. 2) . In two clinically normal donors who smoked, 24 and 62% of the cells were NO53-positive.
Diaphorase Cytochemistry. Only small numbers of cells could be diverted from the diagnostic studies for which the bronchoscopies were carried out, and these were promptly fixed for transport. These constraints precluded any direct measurement o f N O production by explanted cells. H o wever, mouse NOS2 in fixed sections can reduce tetrazolium salts (45, 46) . Consistent with this, 293 cells became diaphorase-positive after transfection with NOS2 c D N A (Fig.  4) . With live cells, diaphorase activity can also reflect superoxide produced by the respiratory burst oxidase (47) , an enzyme system present in human pulmonary alveolar macrophages (48) . However, peritoneal macrophages that were activated in vivo and then collected and fixed were diaphorase-negative when they derived from NOS2-deficient mice, whereas those from NOS2-replete mice were diaphorase-positive (Fig. 4) , even though the respiratory burst is normal in macrophages from the NOS2-deficient mice (4). Thus, as applied herein to fixed cells, the diaphorase assay strictly depended on expression of NOS2.
The proportion o f tuberculosis patients' bronchoalveolar lavage cells that were positive by diaphorase cytochemistry (45 "+-27%, 9 subjects) (Fig. 3) 16 tuberculosis patients' samples tested, 12 supported the amplification from NOS2-specific primers of a product that hybridized with a NOS2--specific probe encoded between but not within the regions of the N O S 2 gene used for designing the primers. Visualization of this product was evident after first-round P C R in 7 cases and required nested P C R in the remaining 5. The NOS2-hybridizing product was of the expected size (413 bp) in 9 of the 12 cases (Fig.  5, A and B) . In the other 3 patient samples, the amplified product was larger ("-~500 bp; not shown). In none of the 4 .
healthy volunteers' samples tested did first-round P C R yield a NOS2-specific product. However, nested PCI< yielded a 413-bp, NOS2-hybridizing product in 2 samples from normal donors (Fig. 5 B) and a " 4 0 0 bp product in a third; the fourth remained negative by nested PCR. As a control, 293 cells were transfected with NOS2 cDNA; application of nested R T -P C R demonstrated the expected 413-bp product (Fig. 5 A, lane 2 ; B, lane 1) comigrating with that produced by direct PCt< on NOS2 cDNA (Fig,  5 A, lane 1) . Cloning and sequencing of amplification products of the 413-bp products from one patient and one normal donor confirmed their identity as NOS2. The larger amplificand was also cloned and sequenced from two patients. From the 5' end, the first "o110 bp were identical to NOS2 exon 1 and its junction with intron 1. The 3' end closely matched the exon 4 primer used in PCR, while the intervening portion was of indeterminate origin. These larger amplificands were considered artefacts, and samples yielding them were scored as negative.
Correlation of Results from Three Assays for NOS2. Sam-
ples from 12 tuberculosis patients and 4 healthy volunteers were sufficient for testing by 2 or more of the assays for NOS2 (immunocytochemistry, diaphorase cytochemistry, and IkT-PCI<). For the patients, 2 of 2 samples were positive by all 3 assays, 8 of 10 by each of 2 assays, and the remaining 2 by 1 of 2 assays. In contrast, samples from none of the 4 healthy volunteers tested by 2 assays were positive by both.
Discussion
Many studies of NOS2 expression in human cells have been clouded by lack of evidence for the specificity of the antibodies used or by their subsequently revealed lack of specificity. For example, a mAb reactive with mouse NOS2 and widely used as an anti-human NOS2 reagent was recently shown to bind human NOS1 (49) . To our knowledge, the present report provides the first documentation of the monospecificity of an antibody against human NOS2, and the first evidence for expression of NOS2 protein in human mononuclear phagocytes using such an antibody.
Inducible NOS was detected in a mean of 65% of the pulmonary alveolar macrophages of 100% of 11 patients with newly diagnosed, untreated pulmonary tuberculosis. In contrast, in 5 normal subjects, NOS2-positive alveolar ceils averaged 10% of the bronchoalveolar lavage population. In two clinically normal smokers, NOS2-positive cells were much more frequent (mean 43%). Likewise, extensive NOS2 reactivity was evident in alveolar macrophages from patients with a variety of other pulmonary inflammatory disorders, such as nontuberculous pneumonia (52 + 9% of alveolar lavage cells; n = 5), cancer (24 + 24%; n = 2), sarcoidosis (20%; n = 1) (Bonecini-Almeida, M.G., S. Nicholson, J.B,. Lapa e Silva, C. Nathan, and J.L. Ho, unpublished observations), and nocardiosis (90%; n = 1; Cho, H., W. R.om, and C. Nathan, unpublished observations).
Smoking cannot account for all of the results in patients with tuberculosis, since at least 4 of the 11 did not smoke, and the NO53-positivity ofmacrophages in this subset was if anything more extensive than among the smokers. The substantially greater degree of NOS2 expression in alveolar macrophages of tubercular compared to normal subjects may signify that NOS2 was induced in the patients' alveolar macrophages by cytokines and/or mycobacterial products (50).
First-round R.T-PCR was positive for NOS2 with 7 samples from 16 tuberculosis patients but not with samples from the 4 normals. The latter results are consistent with a recent study in which first-round P,T-PCP, was negative for NOS2 when applied to pulmonary alveolar macrophages from 4 normal subjects (51) . In the present work, however, nested PCP,. with Southern blot detection was positive in 2 of 4 normal subjects' samples, consistent with the presence of a few NOS2-positive cells by immunocytochemistry. The difference between the present work and the study of Guo et al. (51) with respect to an occasional minor representation versus a complete lack of NOS2-positive macrophages in normal subjects might be attributable to the presence of subclinical pulmonary inflammation in some of our volunteers and/or to differences in assay sensitivity.
Circumstances have been described with human (21) and mouse (52) macrophages in which NOS2 protein was detectable but little or no N O was generated. To test for enzymatic activity in fixed preparations of NOS2-positive cells, we used diaphorase cytochemistry. Under the conditions tested, expression of NOS2 was strictly required for a positive reaction. The proportion of diaphorase-positive pulmonary lavage cells from tuberculous patients matched that of NOS2-positive cells. There is no precedent for expression of a NOS that preserves diaphorase activity but has lost the ability to produce NO. Thus, the expression of diaphorase activity is strong evidence for the presence of the high-output NO pathway before fixation.
When present in human macrophages in vitro, NOS2 appears to contribute to their antimicrobial activity against Mycobacterium avium (16) , Trypanosoma cruzi (I8), and Leishmania major (32) . While there are apparently no such reports for M. tuberculosis, human macrophages do not appear to have been infected in vitro with the latter organism under conditions in which they abundantly expressed NOS2, and thus the experimental conditions seem not to have adequately reproduced the milieu of the infected lung. Given that NOS activity appears to be essential for the control of tuberculous infection in mice (6) (7) (8) , the present findings suggest that NOS2 may constitute an element of the antimycobacterial armamentarium of human macrophages in vivo.
These 
